Royal Bank of Canada’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $124M | Buy |
737,128
+7,434
| +1% | +$1.27M | 0.02% | 567 |
|
|
2025
Q4 | $123M | Buy |
729,694
+165,012
| +29% | +$26.8M | 0.02% | 569 |
|
|
2025
Q3 | $81.5M | Sell |
564,682
-65,857
| -10% | -$8.99M | 0.01% | 785 |
|
|
2025
Q2 | $79.8M | Sell |
630,539
-133,816
| -18% | -$16.4M | 0.01% | 719 |
|
|
2025
Q1 | $97.8M | Sell |
764,355
-441,817
| -37% | -$59.9M | 0.02% | 556 |
|
|
2024
Q4 | $159M | Sell |
1,206,172
-266,253
| -18% | -$37.4M | 0.03% | 420 |
|
|
2024
Q3 | $214M | Buy |
1,472,425
+194,889
| +15% | +$28.2M | 0.04% | 343 |
|
|
2024
Q2 | $175M | Sell |
1,277,536
-39,540
| -3% | -$5.28M | 0.04% | 350 |
|
|
2024
Q1 | $181M | Buy |
1,317,076
+157,418
| +14% | +$21.5M | 0.04% | 345 |
|
|
2023
Q4 | $158M | Sell |
1,159,658
-42,499
| -4% | -$5.19M | 0.04% | 383 |
|
|
2023
Q3 | $147M | Sell |
1,202,157
-96,775
| -7% | -$12.3M | 0.04% | 370 |
|
|
2023
Q2 | $165M | Sell |
1,298,932
-523,930
| -29% | -$68.1M | 0.04% | 359 |
|
|
2023
Q1 | $235M | Sell |
1,822,862
-7,453
| -0.4% | -$976K | 0.07% | 257 |
|
|
2022
Q4 | $240M | Buy |
1,830,315
+124,034
| +7% | +$16M | 0.07% | 251 |
|
|
2022
Q3 | $200M | Buy |
1,706,281
+7,013
| +0.4% | +$871K | 0.06% | 266 |
|
|
2022
Q2 | $200M | Buy |
1,699,268
+421,632
| +33% | +$50.1M | 0.06% | 273 |
|
|
2022
Q1 | $166M | Sell |
1,277,636
-62,619
| -5% | -$8.16M | 0.04% | 342 |
|
|
2021
Q4 | $205M | Buy |
1,340,255
+11,651
| +0.9% | +$1.8M | 0.05% | 322 |
|
|
2021
Q3 | $215M | Buy |
1,328,604
+293,379
| +28% | +$49.4M | 0.06% | 286 |
|
|
2021
Q2 | $169M | Sell |
1,035,225
-165,836
| -14% | -$25.5M | 0.05% | 343 |
|
|
2021
Q1 | $181M | Sell |
1,201,061
-74,504
| -6% | -$11.8M | 0.05% | 307 |
|
|
2020
Q4 | $193M | Buy |
1,275,565
+115,320
| +10% | +$16.5M | 0.06% | 291 |
|
|
2020
Q3 | $157M | Sell |
1,160,245
-77,523
| -6% | -$10.5M | 0.06% | 284 |
|
|
2020
Q2 | $169M | Buy |
1,237,768
+623,560
| +102% | +$79.5M | 0.07% | 241 |
|
|
2020
Q1 | $66.2M | Sell |
614,208
-15,666
| -2% | -$1.8M | 0.03% | 418 |
|
|
2019
Q4 | $75.9M | Sell |
629,874
-63,845
| -9% | -$7.12M | 0.03% | 472 |
|
|
2019
Q3 | $69M | Sell |
693,719
-52,340
| -7% | -$5.48M | 0.03% | 482 |
|
|
2019
Q2 | $81.4M | Sell |
746,059
-48,697
| -6% | -$5.18M | 0.03% | 413 |
|
|
2019
Q1 | $88.9M | Buy |
794,756
+23,852
| +3% | +$2.62M | 0.04% | 379 |
|
|
2018
Q4 | $74.3M | Sell |
770,904
-773
| -0.1% | -$82K | 0.04% | 404 |
|
|
2018
Q3 | $94.1M | Sell |
771,677
-39,217
| -5% | -$4.62M | 0.04% | 378 |
|
|
2018
Q2 | $89.1M | Sell |
810,894
-87,586
| -10% | -$9.37M | 0.04% | 355 |
|
|
2018
Q1 | $95.9M | Buy |
898,480
+27,047
| +3% | +$3M | 0.04% | 355 |
|
|
2017
Q4 | $93M | Sell |
871,433
-288,100
| -25% | -$30.8M | 0.04% | 362 |
|
|
2017
Q3 | $129M | Buy |
1,159,533
+20,025
| +2% | +$2.14M | 0.06% | 264 |
|
|
2017
Q2 | $118M | Sell |
1,139,508
-154,389
| -12% | -$15.2M | 0.06% | 265 |
|
|
2017
Q1 | $126M | Buy |
1,293,897
+259,668
| +25% | +$24.9M | 0.07% | 237 |
|
|
2016
Q4 | $91.5M | Buy |
1,034,229
+381,660
| +58% | +$34.7M | 0.05% | 317 |
|
|
2016
Q3 | $63M | Buy |
652,569
+138,615
| +27% | +$13.2M | 0.04% | 412 |
|
|
2016
Q2 | $44.1M | Buy |
513,954
+32,724
| +7% | +$2.94M | 0.03% | 531 |
|
|
2016
Q1 | $41.8M | Sell |
481,230
-65,451
| -12% | -$5.85M | 0.03% | 533 |
|
|
2015
Q4 | $61.7M | Buy |
546,681
+39,849
| +8% | +$4.33M | 0.04% | 365 |
|
|
2015
Q3 | $51.2M | Sell |
506,832
-10,731
| -2% | -$1.29M | 0.04% | 349 |
|
|
2015
Q2 | $63.7M | Buy |
517,563
+45,456
| +10% | +$5.44M | 0.04% | 306 |
|
|
2015
Q1 | $54M | Buy |
472,107
+25,563
| +6% | +$2.82M | 0.04% | 366 |
|
|
2014
Q4 | $45.2M | Sell |
446,544
-18,477
| -4% | -$1.8M | 0.03% | 455 |
|
|
2014
Q3 | $42.4M | Buy |
465,021
+122,604
| +36% | +$10.8M | 0.03% | 436 |
|
|
2014
Q2 | $29.3M | Buy |
342,417
+54,912
| +19% | +$4.33M | 0.02% | 591 |
|
|
2014
Q1 | $22.7M | Sell |
287,505
-76,353
| -21% | -$6.36M | 0.02% | 699 |
|
|
2013
Q4 | $27.5M | Buy |
363,858
+139,299
| +62% | +$9.88M | 0.02% | 618 |
|
|
2013
Q3 | $15.7M | Buy |
224,559
+41,820
| +23% | +$2.74M | 0.01% | 870 |
|
|
2013
Q2 | $10.6M | Buy |
+182,739
| New | +$10.6M | 0.01% | 1008 |
|
Other funds holding IBB
CB
Royal Bank of Canada's IBB Position: Q1 2026 in Review
Royal Bank of Canada increased its iShares Biotechnology ETF (IBB) stake by 1% in Q1 2026, buying an estimated $1.27M and bringing the position to 737,128 shares worth $124M. The position accounts for 0.02% of the portfolio, ranked #567.
Royal Bank of Canada first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $240M in Q4 2022. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Royal Bank of Canada held 737,128 shares of iShares Biotechnology ETF worth $124M as of Q1 2026.
- Royal Bank of Canada bought 7,434 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.27M.
- iShares Biotechnology ETF made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #567 holding.
- Royal Bank of Canada first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's iShares Biotechnology ETF position peaked at $240M in Q4 2022.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.